Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Unknown 1Completed 1

Sponsor Class

NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Ovarian Neoplasms 4Fallopian Tube Neoplasms 3Brenner Tumor 2Carcinoma, Ovarian Epithelial 1

Interventions

Paclitaxel 24Carboplatin 21Taxes 15Bevacizumab 9Cisplatin 7Immunoglobulin G 6Disulfides 6Topotecan 3Docetaxel 3paclitaxel poliglumex 2VTX-2337 2SS1(dsFv)PE38 2Platinum 2Peripheral Blood Stem Cell Transplantation 2Gemcitabine 2Filgrastim 2Etoposide 2Erlotinib Hydrochloride 2Chemotherapy, Adjuvant 21,2-diaminocyclohexaneplatinum II citrate 2veliparib 1trioctyl phosphine oxide 1sargramostim 1pegfilgrastim 1liposomal doxorubicin 1emactuzumab 1elesclomol 1dexamethasone acetate 1dexamethasone 21-phosphate 1belinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Brenner Tumor × paclitaxel poliglumex × Gynecologic × Clear all
NCT00108745 2021-09-30

Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer

GOG Foundation

Phase 3 Unknown
1,157 enrolled 15 charts
Gynecologic

Brenner Tumor, Fallopian Tube Neoplasms

NCT00060359 2015-05-08

Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer

GOG Foundation

Phase 1 Completed
32 enrolled
Gynecologic

Brenner Tumor, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡